Pretreated baseline neutrophil count and chemotherapy‐induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 8, 2015-08 ,pp. : 854-859

John Wiley & Sons Inc

Access to resources Recommend Favorite

Burden of febrile neutropenia in the Netherlands

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 2, 2015-03 ,pp. : 232-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials

By Pinto Lionel   Liu Zhimei   Doan Quan   Bernal Myriam   Dubois Robert   Lyman Gary  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2283-2295

Informa Healthcare

Access to resources Recommend Favorite

Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain

By Mayordomo José Ignacio   López Andrés   Viñolas Núria   Castellanos Javier   Pernas Sonia   Domingo Alonso Juan   Frau Adolfo   Layola Miquel   Antonio Gasquet José   Sánchez Jordi  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2533-2542

Informa Healthcare

Access to resources Recommend Favorite

G-CSF in the Prevention of Febrile Neutropenia in Chemotherapy in Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 171-178

Karger

Access to resources Recommend Favorite